Atlas Trials

A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India

Clinical trial NCT06086353 · COMPLETED

Trial details

NCT number
NCT06086353
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Transthyretin Amyloid Cardiomyopathy
Start date
2024-03-25
Primary completion
2025-06-06
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.